Mutations in non-tumoral human urothelium: disease prelude or epilogue?

Piedrafita, Gabriel; Fernández, Luis; Real, Francisco X.

doi:http://dx.doi.org/10.3233/BLC-200363

Mutations in non-tumoral human urothelium: disease prelude or epilogue?

License

Citation

Piedrafita G, Fernández LC, Real FX. Mutations in non-tumoral human urothelium: disease prelude or epilogue?. Bladder Cancer. 2020; 6(3):249-52. DOI: 10.3233/BLC-200363

Abstract

Bladder cancer is characterized by high rates of recurrence and multifocality, features which have commonly been associated with the colonization of widespread areas of non-neoplastic urothelium by mutant cells, a phenomenon known as field change. Whether mutant fields in the bladder arise from tumor cells or develop from the accumulation of somatic mutations followed by clonal expansions of non-transformed progenitor cells during lifetime remains unanswered. In this issue, Strandgaard et al. perform a deep-sequencing analysis of paired samples of tumor and histologically normal-appearing urothelium from four patients with advanced bladder cancer. By using a careful validation process, they report several mutations exclusive of normal, non-neoplastic tissue, suggesting that multiple fields precede (or develop independently from) the disease. Here, we discuss the main results from this work and elaborate on the biological implications and open questions in the context of normal somatic clonal evolution and cancer risk. We finish providing some general guidelines for future experiments to resolve the role of field changes in bladder carcinogenesis and its possible clinical relevance.